Department of General Surgery, Colorectal Cancer Center, West China Hospital, Sichuan University, No. 37 Guoxue Lane, Chengdu, 610041, Sichuan Province, China.
Department of Radiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
J Cancer Res Clin Oncol. 2023 Jul;149(7):3905-3914. doi: 10.1007/s00432-022-04305-6. Epub 2022 Aug 26.
Lymph node status is critical for staging rectal cancer and determining neoadjuvant therapy regimens. Establishing a matching between imaging and histopathological lymph nodes is fundamental for predicting lymph node status. This study reports a technique to achieve node-by-node pairing of mesorectal lymph nodes between imaging findings and histopathology.
Fifty-two patients with histopathologically verified rectal cancer underwent magnetic resonance imaging before surgery. The status of each lymph node in the surgical specimens was analyzed histopathologically and matched with preoperative imaging after the operation.
A total of 346 mesorectal lymph nodes were located on imaging evaluation, of which 313 were confirmed histopathologically, and 33 were unmatched. The total success rate of the technique was 90.5%. Node-by-node analysis revealed 280 benign and 33 malignant nodal structures.
The technique to match mesorectal lymph node imaging findings to histopathology was feasible and effective. It simplified the technical method and had a reasonable success matching rate, which could provide a standardized approach for obtaining a prospective correlation between imaging and histological findings, supporting all subsequent related studies at the level of mesorectal lymph nodes.
淋巴结状态对直肠癌分期和确定新辅助治疗方案至关重要。建立影像学和组织病理学淋巴结之间的匹配关系对于预测淋巴结状态至关重要。本研究报告了一种在影像学发现和组织病理学之间实现直肠系膜淋巴结逐节点配对的技术。
52 例经组织病理学证实的直肠癌患者在术前接受了磁共振成像检查。对手术标本中每个淋巴结的状态进行组织病理学分析,并在手术后与术前影像学进行匹配。
共在影像学评估中定位了 346 个直肠系膜淋巴结,其中 313 个在组织病理学上得到证实,33 个未匹配。该技术的总成功率为 90.5%。逐节点分析显示 280 个良性和 33 个恶性淋巴结结构。
将直肠系膜淋巴结影像学表现与组织病理学相匹配的技术是可行且有效的。它简化了技术方法,具有合理的成功匹配率,可以为获得影像学和组织学表现之间的前瞻性相关性提供一种标准化方法,为直肠系膜淋巴结水平的所有后续相关研究提供支持。